LMT: Reiterating Overweight Rating & Raising Target Price Post 3Q; Backlog Expansion Points to Positive Outlook Ahead
Key Points We’re raising our forecast and target price for LMT as we update our outlook for the first time post 3Q earnings. Our target price rises USD40 to USD605 on...